Alpine Immune Sciences, Inc. Skyrocketed
Thu, Nov 02, 2023 at 07:22 PM
Alpine Immune Sciences, Inc. (ALPN:NASDAQ) rocketted at $14.72, a gain of 39.9%. On Thu, Nov 02, 2023, ALPN:NASDAQ touched a New 2-Week High of $14.72. The stock appeared on our News Catalysts scanner on Thu, Nov 02, 2023 at 11:24 AM in the 'BIOTECH' category. From Thu, Oct 19, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About Alpine Immune Sciences, Inc. (ALPN:NASDAQ)
Nivalis Therapeutics Inc a pharmaceutical company, focuses on the discovery and development of product candidates for patients with cystic fibrosis. Geographically operation of the group is functioned through United States.
Top 10 Gainers:
- Vinco Ventures Inc. (BBIG:NASDAQ), 275%
- Signature Bank (SBNY:NASDAQ), 220%
- Virios Therapeutics Inc. (VIRI:NASDAQ), 57.2%
- Baijiayun Group Ltd Ord Cl A (RTC:NASDAQ), 53.54%
- Benson Hill Inc. (BHIL:NYSE), 52.63%
- Lemonade Inc. (LMND:NYSE), 47%
- Aware, Inc. (AWRE:NASDAQ), 45.71%
- Rocky Brands, Inc. (RCKY:NASDAQ), 43.73%
- VS Media Holdings Limited (VSME:NASDAQ), 41.2%
- Alpine Immune Sciences, Inc. (ALPN:NASDAQ), 39.92%